Avecho Biotechnology Stock Quote AVE - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Australia
ASX
Avecho Biotechnology Limited (AVE) Quote

Avecho Biotechnology Limited (AVE)

0.004

0.00

( 0.00% )

Updated: 19:00:00

Delayed by 20 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

0.004

Bid

0.003

Ask

0.004

Volume

0.00

0.00 Day's Range 0.00

0.001 52 Week Range 0.005

Market Cap

Previous Close

0.004

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

4,814,244

Shares Outstanding

3,169,297,013

Dividend Yield

-

PE Ratio

0.00

Earnings Per Share (EPS)

-0

Revenue

1.59M

Net Profit

-3.44M

Sector

Pharmaceutical Preparations

Industry

Financial Services Div'd

Website

www.avecho.com.au

Headquarters

Melbourne, Victoria, Aus

Founded

1992

Avecho Biotechnology Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker AVE. The last closing price for Avecho Biotechnology was AUD0. Over the last year, Avecho Biotechnology shares have traded in a share price range of AUD 0.001 to AUD 0.005.

Avecho Biotechnology currently has 3,169,297,013 shares outstanding. The market capitalization of Avecho Biotechnology is AUD12.68 million. Avecho Biotechnology has a price to earnings ratio (PE ratio) of 0.00.

Aventis Named to List of Top 100 Companies for Working Mothers

Aventis Named to List of Top 100 Companies for Working Mothers Receives Honors Three Years Running BRIDGEWATER, N.J., Sept. 21 /PRNewswire-FirstCall/ -- For the third year in a row, Aventis has...

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity PARIS, Sept. 16 /PRNewswire-FirstCall/ -- The sanofi-aventis Group launched an advertising...

Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent

Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent BRIDGEWATER, N.J., July 27 /PRNewswire-FirstCall/ -- Aventis announced today that it received a second rejection from...

New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes

New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes SYNERGY, A to Z and a Systematic Overview of Six Randomized Trials Published in JAMA...

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 23 /PRNewswire-FirstCall/ -- On June 22, 2004, the Autorite des marches financiers (AMF) -- the French stock market...

Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend

Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend PARIS, June 14 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo (PARIS: SAN, NYSE: SNY) announces that...

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 1 /PRNewswire-FirstCall/ -- On June 1, 2004, the Autorite des marches financiers (AMF) -- the French stock market...

Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement

Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement World's Largest Vaccine Developer to Produce Investigational Vaccine for Clinical Trials SWIFTWATER, Pa., May 27...

Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004

Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004 PARIS, May 26 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo (PARIS: SAN, NYSE: SNY) announces that pending the...

Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients

Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients Findings Presented Suggest Minimal Potential for Adverse Effects Commonly Seen With Inhaled...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.001	33.3333333333	0.003	0.004	0.0025	19459960	0.00334585	DE
4	0.002	100	0.002	0.004	0.002	5782969	0.00330508	DE
12	0.0015	60	0.0025	0.004	0.001	4814244	0.00263522	DE
26	0.001	33.3333333333	0.003	0.004	0.001	3079818	0.00257773	DE
52	0.001	33.3333333333	0.003	0.005	0.001	3577024	0.00333595	DE
156	-0.011	-73.3333333333	0.015	0.023	0.001	2226940	0.00583966	DE
260	0	0	0.004	0.045	0.001	2908842	0.0146171	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PENPeninsula Energy Ltd	AUD 1.115 (1,927.27%)	132.62k
SPASpacetalk Ltd	AUD 0.18 (958.82%)	5k
ADNOCAndromeda Metals Limited	AUD 0.002 (100.00%)	245.92k
EELENRG Elements Ltd	AUD 0.002 (100.00%)	250k
ARNOAldoro Resources Limited	AUD 0.049 (63.33%)	145k
CYBAUCyber Ltd	AUD 0.13 (-35.00%)	643.75k
HCDHydrocarbon Dynamics Limited	AUD 0.002 (-33.33%)	12k
EDEEden Innovations Ltd	AUD 0.001 (-33.33%)	470k
AMDArrow Minerals Limited	AUD 0.0015 (-25.00%)	2.93M
FFGOFatfish Group Limited	AUD 0.003 (-25.00%)	2.54M
MMIMetro Mining Ltd	AUD 0.06 (-4.76%)	167.35M
ROGRed Sky Energy Limited	AUD 0.009 (-18.18%)	28.08M
CRRCritical Resources Limited	AUD 0.0065 (8.33%)	20.01M
VFXVisionflex Group Ltd	AUD 0.003 (0.00%)	18.7M
BGEBridge SaaS Ltd	AUD 0.025 (25.00%)	16.6M

oilin07

oilin07 3 minutes ago

If we announced we are exploring for gold this would have went to .10 with this share structure

HoldEm777

HoldEm777 4 minutes ago

Still clearing debt. After being told all debt was settled. Now ain’t that a bitch….just sayin

theorysuit

theorysuit 4 minutes ago

Not sure why my opinions bother you. The future is in LP’s hands. Nothing you or I say on this message board will have any impact on the share price

I'm not sure why that is so hard to understand. I think the company has paid these folks aka Weintraub on the sec filings.....

Running Q

Running Q 4 minutes ago

E*Trade update: after the third transfer I got to the Corporate Action Division and talked to Glen (he said it’s a small team, M-F from 0800-1800 EST) I explained the situation and he couldn’t find any records of the corporate transaction and said if I had any to upload them to my account and they’

Ecomike

Ecomike 4 minutes ago

The 90% gross profit Margin listed in the financial filings, I guess it is to hard for a dull knife to figure that out?

Money hunt

Money hunt 4 minutes ago

After the RS... We'll still be able to buy shares for under $10 that may still have a significant upside... like $TSLA when it was under $20 per share... And we'll still have a cool story to tell about finding the Company who cured Metastatic Cancer before the mainstream did... we just won't be tell

tdbowieknife

tdbowieknife 4 minutes ago

Ooops... Wrong link for the Brett Rosen suit.

The correct link:

Complaint:
https://drive.google.com/file/d/1EBADDUjSCA1fZ292yNTCz8bOUMDu2RG9/view

.

Buyer Beware
Pump and Dump
http://images.investorshub.advfn

Gman3343

Gman3343 4 minutes ago

Meaning , it's not working ? That's not good at all. After all we were all told that the sea searcher was so precise finding precious metals.
No upda5es in a while, most likely won't get any until spring.
But who knows, even a blind squirrel gets a nut once and a while.

Doc logic

Doc logic 4 minutes ago

dstock07734,

What is really funny is that before you were on this board the shorts used to say that lack of a strong immune response meant that L was just a placebo. A sustained immune response of course was the goal since a strong immune response could be life threatening in the bra

oilin07

oilin07 5 minutes ago

This will easily breakout into multiple pennies with the right string of news

mascale

mascale 7 minutes ago

The mainland China news--banning of mineral exports--may have been a backdrop for the CFO tweet 12/3. It may have also expanded a bit--the 11/20 PR. "We have identified several mid- to large-cap industrial companies and are currently in talks with them for potential mergers with HIRU. These compan

Gman3343

Gman3343 7 minutes ago

I agree, time is running out for Juno. There's no more excuses. If there is no treasure at Juno they will have to try the tech on another site and that will take time.
By the time that happens the pps will be back in the toilet.
Hopefully we hear news soon, but I'm really tired of sayi

JD400

JD400 7 minutes ago

Golfing Really Matters

Old Stud loaded up yesterday close 8.24

Sold on the 1st green after a hole in one 9.24

Always load up the night before on them snipe drives

Stud knows they always buy gold stocks the day after "Record SP Highs"

cjstocksup

cjstocksup 7 minutes ago

2 of you said 4. Did anyone read the thread to see if there is an answer? If anyone does let me know. The other 2 of us said 2.

MasterBlastr

MasterBlastr 7 minutes ago

Alliance of Diehards, Season 2 Week #14 wrapup -
Congrats to all our winners and players this week -

11/28/24 - NFL Thursday 2:30 pm Total Yards - Superstud77
12/01/24 - NFL Sunday 11 am (12 games) - LagoonGoons

SS77

ShawnP123

ShawnP123 8 minutes ago

Not worried about that. When Blackwell starts shipping, that one won't matter. SMCI will be coming on strong if Nvidia shipps them Blackwell. If not them IonQ with theirs in conjunction with integrated Backwell.

HoldEm777

HoldEm777 8 minutes ago

Nah. Several more to go.

bar1080

bar1080 9 minutes ago

I'm seeing that ads for "Trading Robots" are_back, with "monthly average profits of 10.02%."

Is anyone that stupid? yep. If history is any guide, plenty will fall for it... AGAIN.

cjstocksup

cjstocksup 11 minutes ago

https://x.com/RadioGenoa/status/1863474994426052821

Howzitgoing

Howzitgoing 11 minutes ago

Total Vol 138,815,633
Dec 3, 2024
> Buy: 112M
> Neutral: 19M
> Sell: 6M

Notice all the covering lately?

Roofus

Roofus 12 minutes ago

Thanks ….

Hopefully things are still on pace.

JoJr

JoJr 12 minutes ago

Let's hope they will be as generous with share holders :)

Avecho Biotechnology

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions